General MedicationsINTRAVENOUSStandard
PEMETREXED DISODIUM
PEMETREXED DISODIUM
Standard Dose
EQ 100MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PEMETREXED DISODIUM is listed in Drugs@FDA under application 216582 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PEMETREXED DISODIUM Form and strength POWDER;INTRAVENOUS - EQ 100MG BASE/VIAL Sponsor PRINSTON INC Submission history Latest submission status date: 2023-12-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview PEMETREXED DISODIUM is listed in Drugs@FDA under application 216582 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PEMETREXED DISODIUM Form and strength POWDER;INTRAVENOUS - EQ 100MG BASE/VIAL Sponsor PRINSTON INC Submission history Latest submission status date: 2023-12-11 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.